Free Trial

Abrdn Healthcare Investors (HQH) Competitors

Abrdn Healthcare Investors logo
$15.42 -0.62 (-3.87%)
Closing price 05/22/2025 03:59 PM Eastern
Extended Trading
$15.42 0.00 (0.00%)
As of 05/22/2025 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

HQH vs. PTY, ADX, USA, NUV, GAB, RVT, STEW, OXLC, BCAT, and CET

Should you be buying Abrdn Healthcare Investors stock or one of its competitors? The main competitors of Abrdn Healthcare Investors include PIMCO Corporate & Income Opportunity Fund (PTY), Adams Diversified Equity Fund (ADX), Liberty All-Star Equity Fund (USA), Nuveen Municipal Value Fund (NUV), The Gabelli Equity Trust (GAB), Royce Value Trust (RVT), SRH Total Return Fund (STEW), Oxford Lane Capital (OXLC), BlackRock Capital Allocation Term Trust (BCAT), and Central Securities (CET). These companies are all part of the "financial services" industry.

Abrdn Healthcare Investors vs.

PIMCO Corporate & Income Opportunity Fund (NYSE:PTY) and Abrdn Healthcare Investors (NYSE:HQH) are both finance companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, institutional ownership, valuation, analyst recommendations, media sentiment, dividends, earnings, community ranking and risk.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
PIMCO Corporate & Income Opportunity Fund$230.95M10.74N/AN/AN/A
Abrdn Healthcare Investors$186.46M4.45N/AN/AN/A

PIMCO Corporate & Income Opportunity Fund received 1 more outperform votes than Abrdn Healthcare Investors when rated by MarketBeat users. However, 65.08% of users gave Abrdn Healthcare Investors an outperform vote while only 64.92% of users gave PIMCO Corporate & Income Opportunity Fund an outperform vote.

CompanyUnderperformOutperform
PIMCO Corporate & Income Opportunity FundOutperform Votes
124
64.92%
Underperform Votes
67
35.08%
Abrdn Healthcare InvestorsOutperform Votes
123
65.08%
Underperform Votes
66
34.92%

PIMCO Corporate & Income Opportunity Fund pays an annual dividend of $1.42 per share and has a dividend yield of 10.4%. Abrdn Healthcare Investors pays an annual dividend of $2.32 per share and has a dividend yield of 15.0%.

PIMCO Corporate & Income Opportunity Fund has a beta of 0.86, meaning that its share price is 14% less volatile than the S&P 500. Comparatively, Abrdn Healthcare Investors has a beta of 0.79, meaning that its share price is 21% less volatile than the S&P 500.

10.3% of PIMCO Corporate & Income Opportunity Fund shares are owned by institutional investors. Comparatively, 32.6% of Abrdn Healthcare Investors shares are owned by institutional investors. 7.3% of Abrdn Healthcare Investors shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

In the previous week, Abrdn Healthcare Investors had 4 more articles in the media than PIMCO Corporate & Income Opportunity Fund. MarketBeat recorded 5 mentions for Abrdn Healthcare Investors and 1 mentions for PIMCO Corporate & Income Opportunity Fund. Abrdn Healthcare Investors' average media sentiment score of 1.73 beat PIMCO Corporate & Income Opportunity Fund's score of 1.69 indicating that Abrdn Healthcare Investors is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
PIMCO Corporate & Income Opportunity Fund
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
Abrdn Healthcare Investors
4 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

Company Net Margins Return on Equity Return on Assets
PIMCO Corporate & Income Opportunity FundN/A N/A N/A
Abrdn Healthcare Investors N/A N/A N/A

Summary

Abrdn Healthcare Investors beats PIMCO Corporate & Income Opportunity Fund on 6 of the 10 factors compared between the two stocks.

Get Abrdn Healthcare Investors News Delivered to You Automatically

Sign up to receive the latest news and ratings for HQH and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

HQH vs. The Competition

MetricAbrdn Healthcare InvestorsInvestment offices IndustryFinance SectorNYSE Exchange
Market Cap$863.95M$6.92B$11.47B$19.30B
Dividend Yield14.63%6.79%5.45%3.83%
P/E RatioN/A3.5722.4234.53
Price / Sales4.4521.8627.6234.84
Price / CashN/A7.5117.6217.51
Price / BookN/A0.882.774.69
Net IncomeN/A$66.51M$1.03B$1.02B
7 Day Performance-1.88%-0.92%-1.34%-2.43%
1 Month Performance-2.22%2.85%5.24%6.27%
1 Year Performance-7.22%0.98%538.04%5.78%

Abrdn Healthcare Investors Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
HQH
Abrdn Healthcare Investors
N/A$15.42
-3.9%
N/A-8.3%$863.95M$186.46M0.00147,000Positive News
Dividend Increase
Gap Down
PTY
PIMCO Corporate & Income Opportunity Fund
N/A$13.88
+0.6%
N/A-4.1%$2.52B$230.95M0.00147,000Positive News
ADX
Adams Diversified Equity Fund
N/A$20.37
-0.1%
N/A+0.0%$2.39B$564.12M0.0030Positive News
USA
Liberty All-Star Equity Fund
N/A$6.66
-0.9%
N/A-3.4%$1.80B$259.99M0.00N/A
NUV
Nuveen Municipal Value Fund
N/A$8.62
+0.2%
N/A-0.5%$1.79B$200.53M0.00640News Coverage
GAB
The Gabelli Equity Trust
N/A$5.77
+0.3%
N/A+2.2%$1.77B$203.01M0.00N/APositive News
RVT
Royce Value Trust
N/A$14.96
-1.1%
N/A-2.4%$1.73B$9.80M0.0050Positive News
STEW
SRH Total Return Fund
N/A$17.84
-0.1%
N/A+19.7%$1.72B$550.34M0.00N/A
OXLC
Oxford Lane Capital
1.9534 of 5 stars
$4.72
-3.3%
N/A-18.5%$1.63B$194.42M5.69601Gap Down
High Trading Volume
BCAT
BlackRock Capital Allocation Term Trust
N/A$14.77
-0.5%
N/A-11.8%$1.59B$197.67M0.00147,000Positive News
CET
Central Securities
N/A$46.75
-0.5%
N/A+6.7%$1.35B$296.20M0.006Positive News

Related Companies and Tools


This page (NYSE:HQH) was last updated on 5/23/2025 by MarketBeat.com Staff
From Our Partners